Clinical and Molecular Hepatology
ISSN 2287-2728 · Korean Association for the Study of the Liver · South Korea · active 1982–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Clinical and Molecular Hepatology a predatory journal?
Our screening does not flag Clinical and Molecular Hepatology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.
Is Clinical and Molecular Hepatology indexed in Scopus or Web of Science?
Per our venue index, Clinical and Molecular Hepatology appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Clinical and Molecular Hepatology's impact?
Papers in Clinical and Molecular Hepatology are cited about 4.7 times each within two years of publication, and Scimago places it in Q1, with an h-index of 81. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Clinical and Molecular Hepatology open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Similar venues
- Nature Reviews Disease PrimersQ1 · Nature Portfolio
- Journal of Extracellular VesiclesQ1 · Taylor & Francis
- Advanced Drug Delivery ReviewsQ1 · Elsevier BV
- Nature Reviews Gastroenterology & HepatologyQ1 · Nature Portfolio
- Journal of NanobiotechnologyQ1 · BioMed Central
- The Lancet. Gastroenterology & hepatologyQ1 · Elsevier BV